Adma Biologics reported $388.3M in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamis Pharmaceuticals ADMP:US 0.09B 0B
Adma Biologics ADMA:US $ 0.36B 0.08B
Agile Therapeutics AGRX:US $ 0B 0.06B
Alnylam Pharmaceuticals ALNY:US $ 19.71B 0.57B
Antares Pharma ATRS:US $ 0.7B 0.09B
Biocryst Pharmaceuticals BCRX:US $ 3B 0.51B
China Cord Blood CO:US 0.51B 0.06B
Dynavax Technologies DVAX:US $ 1.35B 0.33B
Minerva Neurosciences NERV:US $ 0.04B 0B
Novavax NVAX:US $ 5.62B 5.2B
Omeros OMER:US $ 0.38B 0.03B
Takeda 4502:JP 5534.72B 571.19B